Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-07 | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S
(Director) |
S | Common Stock | D | 5000 | $350.00 - $350.00 | $1,750,000 |
| 2024-11-07 | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S
(Director) |
M | Common Stock | A | 5000 | $7.36 - $7.36 | $36,800 |
| 2024-11-01 | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S
(Director) |
S | Common Stock | D | 5000 | $300.10 - $304.29 | $1,504,703 |
| 2024-11-01 | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S
(Director) |
M | Common Stock | A | 5000 | $7.36 - $7.36 | $36,800 |
| 2024-09-13 | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B
(Director) |
G | Common Stock | D | 15000 | $0.00 - $0.00 | $0 |
| 2024-09-09 | MADRIGAL PHARMACEUTICALS, INC. | Sibold William John
(President and CEO) |
S | Common Stock | D | 6363 | $243.83 - $243.83 | $1,551,490 |
| 2024-08-15 | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T
(General Counsel) |
A | Common Stock | A | 5215 | $0.00 - $0.00 | $0 |
| 2024-06-25 | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B
(Director) |
A | Common Stock | A | 714 | $0.00 - $0.00 | $0 |
| 2024-06-25 | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH
(Director) |
A | Common Stock | A | 714 | $0.00 - $0.00 | $0 |
| 2024-06-25 | MADRIGAL PHARMACEUTICALS, INC. | Daly James M
(Director) |
A | Common Stock | A | 714 | $0.00 - $0.00 | $0 |
| 2024-06-25 | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S
(Director) |
A | Common Stock | A | 714 | $0.00 - $0.00 | $0 |
| 2024-06-25 | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A
(Director) |
A | Common Stock | A | 714 | $0.00 - $0.00 | $0 |
| 2024-06-14 | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E.
(Senior VP, Chief Pharma Dev.) |
S | Common Stock | D | 1900 | $280.00 - $280.00 | $532,000 |
| 2024-06-14 | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E.
(Senior VP, Chief Pharma Dev.) |
M | Common Stock | A | 1900 | $87.09 - $87.09 | $165,471 |
| 2024-06-12 | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E.
(Senior VP, Chief Pharma Dev.) |
S | Common Stock | D | 2000 | $285.00 - $285.00 | $570,000 |
| 2024-06-12 | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E.
(Senior VP, Chief Pharma Dev.) |
M | Common Stock | A | 2000 | $87.92 - $87.92 | $175,840 |
| 2024-06-11 | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B
(Director) |
G | Common Stock | D | 84852 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |